Viatris Inc. (VTRS) holds an SIA SMAX score of 8 out of 10, reflecting broad strength across the asset classes measured. The stock currently ranks 106th out of 500 holdings in the SIA S&P 500 Index Report and remains positioned in the favored green zone. Within the report, VTRS has moved up 26 positions over the past month, although it remains down 47 positions over the past quarter, suggesting a recent improvement within a longer-term relative ranking pullback.
From a Point and Figure perspective, the stock’s last signal was a Double Top, with near-term support at the 3-box reversal level of $13.83. Additional support appears at $12.78, followed by a longer-term support zone between $10.91 and $10.69. Resistance is currently noted at $16.21, with further upside resistance levels at $18.62 and $21.38.
Sector positioning provides a more balanced backdrop. The Drugs sector sits in the neutral yellow zone of the SIA Sector Report, ranking 14th out of 31 sectors. This suggests that while VTRS has shown improving stock-specific relative strength, its broader sector backdrop remains more neutral than strongly favoured.
Performance has been comparatively strong across the reported periods. VTRS has returned +10.34% over the past month, +15.88% over the past quarter, and +85.84% over the past year, compared with the S&P 500 Index at +9.96%, +4.20%, and +29.01%, respectively. The stock’s stronger quarterly and yearly performance may help explain its continued placement in the favored green zone, despite some relative ranking softness over the past quarter.
Viatris Inc. is a U.S.-based global healthcare and pharmaceutical company formed in 2020 through the merger of Mylan and Pfizer’s Upjohn division. The company develops, manufactures, and distributes branded drugs, generics, and biosimilars, serving patients in more than 165 countries.
Disclaimer: SIACharts Inc. specifically represents that it does not give investment advice or advocate the purchase or sale of any security or investment whatsoever. This information has been prepared without regard to any particular investors investment objectives, financial situation, and needs. None of the information contained in this document constitutes an offer to sell or the solicitation of an offer to buy any security or other investment or an offer to provide investment services of any kind. As such, advisors and their clients should not act on any recommendation (express or implied) or information in this report without obtaining specific advice in relation to their accounts and should not rely on information herein as the primary basis for their investment decisions. Information contained herein is based on data obtained from recognized statistical services, issuer reports or communications, or other sources, believed to be reliable. SIACharts Inc. nor its third party content providers make any representations or warranties or take any responsibility as to the accuracy or completeness of any recommendation or information contained herein and shall not be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. Any statements nonfactual in nature constitute only current opinions, which are subject to change without notice.
